Physician profile
Serena H Chen
NPI 1598883571
$20,469.53
in general payments reported to CMS, 2019-2025
13 companies · $333 in 2025
The $333 reported for 2025 was more than what 80% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,960 · 2020: $1,028 · 2021: $5,284 · 2022: $1,441 · 2023: $352 · 2024: $9,072 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,947 · Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,947.00 |
| Food and Beverage | $809.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $9,404.38 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $3,957.31 | 2021 | |
| Emd Serono, INC. | $3,697.92 | 2019-2025 | |
| Hologic Sales and Service, LLC | $2,620.04 | 2019-2025 | Myosure Tissue Removal Device, Novasure, Fluent Fluid Management System |
| Cytyc Prenatal Products Corp. | $437.50 | 2019 | |
| Janssen Pharmaceuticals, INC | $100.17 | 2021 | |
| Organon LLC | $95.75 | 2021-2025 | Follistim Aq, Ganirelix Acetate |
| Merck Sharp & Dohme LLC | $56.98 | 2019-2021 | |
| Richard Wolf Medical Instruments Corp. | $29.97 | 2023 | |
| Abbvie INC. | $27.09 | 2019 | |
| Minerva Surgical, INC | $15.16 | 2023 | |
| Duchesnay USA Incorporated | $14.81 | 2019 | |
| Avion Pharmaceuticals | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Serena Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.